लोड हो रहा है...

Short Interfering RNA against Transient Receptor Potential Vanilloid 1 Attenuates Cisplatin-Induced Hearing Loss in the Rat

Cisplatin, a chemotherapeutic agent of choice for the treatment of solid tumors, produces hearing loss in approximately half a million new cancer patients annually in the United States. The hearing loss is due, in part, to increased generation of reactive oxygen species (ROS) in the cochlea, leading...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Mukherjea, Debashree, Jajoo, Sarvesh, Whitworth, Craig, Bunch, Jennifer R., Turner, Jeremy G., Rybak, Leonard P., Ramkumar, Vickram
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Society for Neuroscience 2008
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2865180/
https://ncbi.nlm.nih.gov/pubmed/19052196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.1307-08.2008
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!